Travers Ching
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Obstetrics and Gynecology top 5%
Papers in
-
- RNA modifications and cancer 8
- RNA Research and Splicing 5
- Gene expression and cancer classification 3
- Single-cell and spatial transcriptomics 3
-
- Cancer-related molecular mechanisms research 12
- Cancer Genomics and Diagnostics 3
- MicroRNA in disease regulation 3
- Co-authors
- Lana X. Garmire (16 shared papers)Xun Zhu (8 shared papers)Sijia Huang (5 shared papers)Lana X. Garmire (4 shared papers)Olivier Poirion (4 shared papers)János Molnár (3 shared papers)Maarit Tiirikainen (3 shared papers)Herbert Yu (3 shared papers)
- Journals
- Nature Communications (2 papers)PLoS Computational Biology (2 papers)International Biodeterioration & Biodegradation (2 papers)Clinical Cancer Research (1 paper)Clinical Epigenetics (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Travers Ching
28 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 124
- Cancer Research 321
- Obstetrics and Gynecology 73
- Molecular Biology 633
- Health Informatics 9
- Biophysics 32
Countries citing papers authored by Travers Ching
This map shows the geographic impact of Travers Ching's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Travers Ching with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Travers Ching more than expected).
Fields of papers citing papers by Travers Ching
This network shows the impact of papers produced by Travers Ching. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Travers Ching. The network helps show where Travers Ching may publish in the future.
Co-authors
The 25 scholars most cited alongside Travers Ching, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 247 | |
| 2 | 2014 | 169 | |
| 3 | 2016 | 80 | |
| 4 | 2017 | 79 | |
| 5 | 2014 | 55 | |
| 6 | 2017 | 54 | |
| 7 | 2014 | 54 | |
| 8 | 2018 | 48 | |
| 9 | 2015 | 47 | |
| 10 | 2015 | 44 | |
| 11 | 2018 | 40 | |
| 12 | 2014 | 40 | |
| 13 | 2016 | 38 | |
| 14 | 2016 | 31 | |
| 15 | 2017 | 29 | |
| 16 | 2015 | 27 | |
| 17 | 2020 | 20 | |
| 18 | 2015 | 18 | |
| 19 | 2019 | 13 | |
| 20 | 2016 | 12 |
About Travers Ching
Travers Ching is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Radiology, Nuclear Medicine and Imaging, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (8 papers), RNA Research and Splicing (5 papers), Cancer Genomics and Diagnostics (3 papers), Gene expression and cancer classification (3 papers), Single-cell and spatial transcriptomics (3 papers), Pregnancy and preeclampsia studies (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (321 citations), Obstetrics and Gynecology (73 citations), Molecular Biology (633 citations), Health Informatics (9 citations) and Biophysics (32 citations). Travers Ching has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Lana X. Garmire, Xun Zhu, Sijia Huang, Lana X. Garmire, Olivier Poirion, János Molnár, Maarit Tiirikainen, Herbert Yu, Min‐Ae Song and Marla J. Berry. Their work appears in journals such as Nature Communications, PLoS Computational Biology, International Biodeterioration & Biodegradation, Clinical Cancer Research and Clinical Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.